Liudmyla O. Turova

Liudmyla O. Turova

Auto-generated profile, based on publicly available information

Liudmyla O. Turova

Bogomolets National Medical University, Kyiv

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 December 2024 in Modern pediatrics. Ukraine
Verified
Journal Article
Open access
PDF file
LTL.о. Turova
L.о. Turova
TVT.A. Vezhnovets
T.A. Vezhnovets
Аim - is to analyze the dynamics of the incidence and prevalence of autism spectrum disorders (ASD) per 100,000 children in Ukraine in the period 2008-2020 and to forecast these indicators until 2025. Materials and methods. A retrospective analysis of the reporting data of the Public Health Center of the Ministry of Health of Ukraine in the period 2008-2017 and of the Institute of Forensic Psychiatry of the Ministry of Health of Ukraine in the period 2018-2020 was carried out. Incidence and prevalence rates per 100,000 child population (0-17 years) were calculated, and the availability of medical geneticists in Ukraine per 1 million population was determined. Calculations of prognostic indicators in 2025 have been carried out. Calculations were performed in the MedCalc® Statistical Software package (v.22.009). Results. In Ukraine, in the period 2008-2020, a reliable trend towards an increase in the prevalence of ASD almost 10 times from 13.82 per 100,000 to 146.03 per 100,000 and the incidence rate from 2.28 to 22.15 per 100,000 of the child population was revealed. A reliable increase in these indicators is predicted by 2025. The number of cases of ASD among urban residents is significantly higher than among urban residents (75.36% versus 24.64%). However, a significant increase in the proportion of ASD cases among rural residents is predicted in 2025. Regional features of the prevalence and morbidity indicators in Ukraine were revealed. The highest incidence rate was found in Kyiv (26.27 per 100,000) and the lowest - in Luhansk region (23.50 per 100,000). The existence of a negative reliable relationship between prevalence and morbidity indicators with the supply of genetic doctors per 1 million population, with the number of visits to them, with the share of primary patients examined and with the share of families registered for the first time was established. Conclusions. In Ukraine, a significant increase in the prevalence and incidence of ASD among the children's population is predicted until 2025, one of the reasons for this increase may be a decrease in access to medical and genetic counseling due to a decrease in the supply of genetic doctors. No conflict of interests was declared by the authors.

20 January 2025 in Clinical and Preventive Medicine
Verified
Journal Article
Open access
PDF file
LTLiudmylа О. Turova
Liudmylа О. Turova
TVTetiana A. Vezhnovets
Tetiana A. Vezhnovets
VKValeriia Y. Kantsypa
Valeriia Y. Kantsypa
ТВТетяна А. Вежновець
Тетяна А. Вежновець
ВКВалерія Є. Канципа
Валерія Є. Канципа
Aim. This study aims to assess the awareness of Ukrainian medical practitioners about personalized medicine, evaluate their readiness to adopt such approaches in clinical practice, and identify barriers that may hinder its implementation. Materials and methods. The study was conducted in the format of a nationwide survey among doctors in Ukraine (n=830). To ensure a representative sample of doctors throughout Ukraine, a random sampling method was used. This allowed for an even coverage of respondents of different age groups, specializations, as well as representatives from different regions. This approach minimized the likelihood of bias and provided accurate results. The survey was developed taking into account the ISO 20252:2019 and ISO 26362:2009 standards, which regulate the processes of marketing, social and public opinion surveys. Descriptive statistical methods were used to analyze the collected data. Data analysis was carried out in the R environment (4.1.2). Conclusions. Key findings revealed significant regional disparities in access to genetic testing and medical-genetic consultations. While positive responses on the availability of resources were more prevalent in western regions and Kyiv, many regions, particularly in eastern and central Ukraine, reported substantial gaps. Factors influencing the acceptance of personalized medicine include access to technology, training, and institutional support, while barriers encompass a lack of infrastructure, limited awareness, and inadequate resources. This study highlights the need for strategic measures to address barriers and foster the development of personalized medicine in Ukraine. Enhanced resource allocation, education, and policy support are critical for integrating personalized approaches into the national healthcare system, ultimately improving patient outcomes and advancing medical practice.

30 August 2024 in Clinical and Preventive Medicine
Verified
Journal Article
Open access
PDF file
LTLiudmyla O. Turova
Liudmyla O. Turova
TVTetiana A. Vezhnovets
Tetiana A. Vezhnovets
ТВТетяна А. Вежновець
Тетяна А. Вежновець
Aim. To study the staffing conditions of the medical-genetic service in Ukraine during the period from 2008 to 2022 and to forecast the staffing dynamics until 2026. Materials and Methods: Statistical data from healthcare institutions in Ukraine that provided medical-genetic services during the period from 2008 to 2022 were analyzed, based on reporting forms 21, 17, 49 from the City Health Center website http://medstat.gov.ua/ukr/statdan.html and http://medstat.gov.ua/ukr/statdanMMXIX.html. Single-factor linear regression models were applied for mathematical modeling, with quality assessment conducted using the coefficient of determination R². Calculations were performed using MedCalc® Statistical Software (v.22.009). Results: Compared to 2008, there was a significant reduction in the number of full-time positions of heads of offices (genetic doctors), genetic doctors, and genetic laboratory doctors in Ukraine in 2022 by -45.24%, -24.83%, and -23.39%, respectively. A significant decrease in the number of these positions was determined (p<0.05). In 2022, compared to 2008, there was also a decrease in the staffing rate of all full-time positions with occupied positions of the personnel of centers/offices. Specifically, for genetic doctors, the staffing rate in 2022 was 69.62% compared to 85.37% in 2008, and for genetic laboratory doctors, it was 57.54% compared to 94.62% in 2022 and 2008, respectively. The level of provision of geneticists (individuals) in Ukraine in 2022 was 1.99 per 1 million population, which is -16.03% less than in 2008. Furthermore, compared to 2008, the share of vacant positions for genetic doctors in 2022 increased 2-fold, and for genetic laboratory doctors almost 8-fold. According to the results of mathematical forecasting, in 2026, a further decrease in the availability of genetic doctors to the level of 1.77 per 1 million population is predicted (R²=0.88, p<0.001). Results. Compared to 2008, there was a significant reduction in the number of full-time positions of heads of offices (genetic doctors), genetic doctors, and genetic laboratory doctors in Ukraine in 2022 by -45.24%, -24.83%, and -23.39%, respectively. A significant decrease in the number of these positions was determined (p<0.05). In 2022, compared to 2008, there was also a decrease in the staffing rate of all full-time positions with occupied positions of the personnel of centers/offices. Specifically, for genetic doctors, the staffing rate in 2022 was 69.62% compared to 85.37% in 2008, and for genetic laboratory doctors, it was 57.54% compared to 94.62% in 2022 and 2008, respectively. Furthermore, in comparison with 2008, the share of vacant positions for genetic doctors in 2022 increased in 2-fold, and for genetic laboratory doctors almost in 8-fold. According to the results of mathematical forecasting, in 2026, a further decrease in the availability of genetic doctors to the level of 1.77 per 1 million population is predicted (R²=0.88, p<0.001). Conclusions. Based on the analysis of staffing of the medical-genetic service in Ukraine during the period 2008-2022, conclusions can be drawn about the reduction in the number of full-time positions and the availability of genetic doctors in the medical-genetic service in Ukraine. To ensure proper medical-genetic counseling for the population, it is necessary to develop an effective strategy for improving the organization of the medical-genetic service, capable of providing comprehensive support for patients with genetic pathologies.

5 October 2023 in Asthma and allergy
Verified
Journal Article
Open access
ЛТЛ. О. Турова
Л. О. Турова
ОНО. М. Науменко
О. М. Науменко
ВБВ. В. Бобир
В. В. Бобир
Резюме. Сучасна ера молекулярно-генетичних технологій дозволяє застосовувати вже сьогодні інноваційні розробки персоналізованої медицини, фенотипування та ендотипування алергічних захворювань. В статті наведені кандидатні гени, що є молекулярними предикторами алергічного риніту (АР). Наявність АР потребує значного збільшення медичних ресурсів, його лікування вимагає мультидисциплінарного підходу з урахуванням імуно- та фармакогенетичного, метаболічного портрету, що корелює з можливістю та ефективністю реабілітаційного потенціалу даної когорти пацієнтів.

27 May 2026
Verified
Journal Article
Open access
RVR.м. Vorona
R.м. Vorona
ОGО.V. Golyanovskiy
О.V. Golyanovskiy
RMR.M. Mitsoda
R.M. Mitsoda
КOК.S. Ostrovets
К.S. Ostrovets
LTL.O. Turova
L.O. Turova
Postpartum hemorrhage (PPH) remains one of the main causes of severe maternal morbidity and mortality. The leading etiological factor of early PPH is uterine atony, which can be refractory when the myometrium is insensitive to uterotonic drugs, tranexamic acid, and palpatory irritation.The objective: to evaluate the comparative effectiveness of the use of a modified low-pressure vacuum system (LPVS) for the treatment of refractory atonic PPH after vaginal delivery in comparison with uterine balloon tamponade (UBT) in terms of the main clinical indicators of achieving hemostasis.Materials and methods. The study was conducted at the clinical bases of the Department of Obstetrics and Gynecology of the Shupyk National Healthcare University of Ukraine in 2023–2025. The study included 64 women with early atonic PPH after vaginal delivery. The parturient women were divided into two groups by simple randomization: group I (n = 31) received the therapy of refractory atonic bleeding using LPVS (70–80 mmHg); group II (n = 33) used UBT for the same purpose.Results. Pregnant women of both groups were representative in terms of general characteristics and risk factors (p > 0.05). The main clinical results in the study groups confirmed the high effectiveness of the use of LPVS in group I compared to group II in terms of the time to stop bleeding and the volume of total blood loss (p < 0.001). In addition, in group I compared to group II there was a lower need for blood transfusions, additional use of uterotonics, and surgical hemostasis, although the difference did not reach statistical significance.Conclusions. The proposed method of LPVS placement into the uterine cavity during vaginal delivery can be considered as a highly effective, affordable, and inexpensive alternative method to UBT and surgical methods of treating refractory atonic bleeding.

28 December 2025 in UKRAINIAN JOURNAL OF PERINATOLOGY AND PEDIATRICS
Verified
Journal Article
Closed access
LTL.O. Turova
L.O. Turova
Aim - to develop and scientifically substantiate a population-based model for the implementation of personalized medicine in pediatric practice within a capable healthcare facility network. Materials and methods. An organizational and analytical study was conducted using a systemic analysis of the regulatory framework governing the formation of a capable healthcare network, a comparative analysis of international experience in integrating genomic medicine, and structural modeling. A multilevel model for the integration of genetic predictors into pediatric practice was developed. Results. A three-tier organizational model (primary, cluster, and supercluster levels) was established to ensure the phased integration of genetic predictors into pediatric healthcare delivery. A population-based algorithm for family genetic support was developed, covering the continuum from the preconception period to the postnatal stage. The model incorporates risk stratification, the development of individualized preventive care pathways, and the establishment of regional registries. Conclusions. The proposed model enables the systematic integration of personalized approaches into pediatric care, facilitates the early identification of genetic risks, and provides a foundation for reducing long-term morbidity and optimizing healthcare resources. The author declares no conflict of interest.